high expression of class iii β-tubulin predicts good response to neoadjuvant taxane and doxorubicincyclophosphamide-based chemotherapy in estrogen receptor–negative breast cancer
本文档由 epv417078 分享于2017-04-23 06:38
high expression of class iii β-tubulin predicts good response to neoadjuvant taxane and doxorubicincyclophosphamide-based chemotherapy in estrogen receptor–negative breast cancer
分享：
君，已阅读到文档的结尾了呢~~